FanzizFanziz
HomeFinanceCricketSoccerEntertainmentEsports
Menu
HomeFinanceCricketSoccerEntertainmentEsportsWWETennisHealth

Language

AllQuick ReadsFanzShots

Ozempic Patent Expiry: Weight-Loss Drug Showdown in India!

Ozempic Patent Expiry: Weight-Loss Drug Showdown in India!

Listen up, folks! Swati Pradhan, the heavyweight champ of obesity clinics in Mumbai, is ready to see her patient count skyrocket! With the Ozempic patent hitting the mat on March 20, Indian drugmakers are gearing up to unleash their budget-friendly versions, making weight loss more accessible than ever. Get ready for a health revolution that'll have everyone shouting for joy!

Quick rundown

  1. Indian drugmakers set to launch cheaper semaglutide versions.
  2. Novo Nordisk's patent expiry sparks obesity drug market expansion.
  3. India's obesity clinics brace for a surge in demand.
  4. High-calorie diets contribute to India's growing obesity issue.
  5. India's GLP-1 market expected to quintuple by 2030.

Related articles

  • Ozempiq and Weight Loss: Real Talk with Dr. Ambrish and JuhiOzempiq and Weight Loss: Real Talk with Dr. Ambrish and Juhi
  • Dr Reddy's to Launch Wegovy Generic at 60% Off—Big League!Dr Reddy's to Launch Wegovy Generic at 60% Off—Big League!
  • Eli Lilly Sets Its Sights on India as Manufacturing PowerhouseEli Lilly Sets Its Sights on India as Manufacturing Powerhouse
  • GLP-1 Drugs: The Chill Pill for Kicking Addictions, Fo' ShizzleGLP-1 Drugs: The Chill Pill for Kicking Addictions, Fo' Shizzle
  • India Takes 2nd Place in Global Childhood Obesity ShowdownIndia Takes 2nd Place in Global Childhood Obesity Showdown

Series

  • Indian Premier League
  • Pakistan Super League
  • South Africa Women tour of New Zealand
  • County Championship Division Two